Meet Steven Weitzman, M.D.
About Dr. Weitzman
Dr. Weitzman graduated from The University at Buffalo School of Medicine in New York. He then completed a residency in Internal Medicine at Albert Einstein/LIJ Medical Center and an additional year as Chief Resident. His fellowship training was at the Stony Brook School of Medicine. Upon completion of fellowship, he joined the faculty at Stony Brook as Assistant Professor and was recognized as a Top Doctor in the NY Metro Area by Castle Connolly. Dr. Weitzman later joined MD Anderson for uniquely comprehensive training in all aspects of Endocrine Neoplasia as the inaugural fellow in Oncologic Endocrinology. He is board certified in Endocrinology and is a member of the Endocrine Society, American Thyroid Association, and the American Association of Clinical Endocrinologists. He sees patients at the Texas Medical Center and in Sugar Land. His clinical interests include thyroid, parathyroid, adrenal, and pituitary.
Present Title & Affiliation
Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
|2002||University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA, MD, Medicine|
|1996||Pace University, Pleasantville, NY, USA, MS, Counseling Psychology|
|1992||Dartmouth College, Hanover, NH, USA, AB, Psychology|
|2008||Endocrinology, Diabetes, and Metabolism, American Board of Internal Medicine|
Experience & Service
Assistant Professor, Department of Medicine, Division of Endocrinology, Stony Brook University School of Medicine (State University of New York), Stony Brook, NY, 2008 - 2014
Committee Member, American Thyroid Association - Trainees and Career Advancement Committee, Falls Church, VA, 2015 - 2021
Member, Stony Brook University School of Medicine, Internal Accreditation Council for Graduate Medical Education (ACGME) Fellowship Program Review Panel, Stony Brook, NY, 2007 - 2008
Institutional Committee Activities
Member, Pharmacy and Therapeutics Committee, 2016 - 2021
Member, House Staff Senate, 2015 - 2015
Member, Medullary Thyroid Cancer Translational Research Working Group, 2014 - Present
Member, Anaplastic Thyroid Cancer and Differentiated Thyroid Cancer Translational Research Working Group, 2014 - Present
Honors & Awards
|2013||Top Doctors: New York Metro Area, Castle Connolly|
|2012||Fellow of the American Association of Clinical Endocrinology, American College of Endocrinology|
- Weitzman SP, Ginsburg KC, Carlson HE. Colesevelam Hydrochloride and Lanthanum Carbonate Interfere with the Absorption of Levothyroxine. Thyroid 19(1):77-9, 2009. PMID: 19119983.
- Weitzman SP, Cabanillas ME. The Treatment Landscape in Thyroid Cancer: A Focus on Cabozantinib. Cancer Manag Res 2015(7):265-78, 2015. e-Pub 2015. PMID: 26316818.